NIKA PHARMACEUTICALS, INC (NIKA): auditor change — Nika Pharmaceuticals dismisses auditor BF Borgers, appoints Fruci & Associates

NIKA PHARMACEUTICALS, INC

Dismissed independent accountant B F Borgers CPA PC effective February 14, 2024.
Engaged Fruci & Associates II, PLLC as new independent auditor on February 14, 2024.
Board states change in best interests; no disagreements or reportable events disclosed.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

NIKA PHARMACEUTICALS, INC engaged Fruci & Associates II, PLLC as its auditor.

Action: engagement
Auditor: Fruci & Associates II, PLLC

Exact text from the filing

On February 14, 2024, Nika Pharmaceuticals, Inc. engaged the firm of Fruci & Associates II, PLLC to serve as the independent accountant to audit the company’s financial statements.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

NIKA PHARMACEUTICALS, INC dismissed B F Borgers CPA PC as its auditor.

Action: dismissal
Auditor: B F Borgers CPA PC
Successor: Fruci & Associates II, PLLC

Exact text from the filing

PA PC on February 14, 2024 and engage Fruci & Associates II, PLLC. The members of the board of directors have discussed the issue with the former

View on SEC.gov

Browse all auditor changes →

NIKA PHARMACEUTICALS, INC filing history →

Source: SEC EDGAR

accession 0001826466-24-000005

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.